52568 Federal Register / Vol. 62, No. 195 / Wednesday, October 8, 1997 / Notices

and identification of factors which may

be important in disease prevention.

Frequency of response: 5.36 (annual

number of responses/annual number of

respondents) Affected public:

Individuals or households. Types of

Respondents: Individuals recruited for

CHS and their selected proxies and

physicians. The annual reporting

burden is as follows: Estimated Number

of Respondents: 5,790; Estimated

Number of Responses per respondent:

5.4; and Estimated Total Annual Burden

Hours Requested: 8,098. There are no

costs for respondents. Estimated

annualized cost for information

collection for information collection for

a 13-year period is $6,820 thousand per

year. This is based on CHS Field, Center

and Reading Centers costs in thousands

per year. Personnel, $3,627; Equipment,

$47; Subcontracts, $257; Other, $1,437;

Overhead, $1,452. The annualized cost

of monitoring the project by the NHLBI

is $207 thousand.

REQUEST FOR COMMENTS: Written

comments and/or suggestions from the

public and affected agencies are invited

on one or more of the following points:

(1) Whether the proposed collection of

information will have practical utility;

(2) The accuracy of the agency’s

estimate of burden of the proposed

collection of information, including the

validity of the methodology and

assumptions used; (3) Ways to enhance

the quality, utility, and clarity of the

information to be collected; and (4)

Ways to minimize the burden of

collection of information on those who

are to respond, including the use of

appropriate automated, electronic,

mechanical, or other technological

collection techniques or other forms of

information technology.

FOR FURTHER INFORMATION: To request

more information on the proposed

project or to obtain a copy of data

collection plans and instruments,

contact Dr. Robin Boineau,

Epidemiology and Biometry Program,

Division of Clinical Applications,

NHLBI, NIH, II Rockledge Centre, 6701

Rockledge Drive, MSC #7934, Βετηεσδα,

Μ∆, 20892–7934, ορ ψαλλ νον-τολλ φρεε

νθμβερ (301) 435–0707, ορ Ε-μαιλ υοθρ

ρεφθεστ, ινψλθδινγ υοθρ αδδρεσσ τοTM

βοινεαθ@νιη.γοω.

COMMENTS DUE DATE: Comments

regarding this information collection are

best assured of having their full effect if

received within 60-days of the date of

this publication.

Dated: October 1, 1997.

Sheila E. Merritt,

Executive Officer, NHLBI.

[FR Doc. 97–26631 Filed 10–7–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Public Health Service

National Institutes of Health

Proposed Data Collection: Public

Comment; Leukemia and Other

Cancers Among Chernobyl Clean-up

Workers in Lithuania

SUMMARY: In compliance with the

requirement of Section 3506 (c) (2) (A)

of the Paperwork Reduction Act of 1995

for opportunity for public comment on

proposed data collection projects, the

National Institutes of Health (NIH),

National Cancer Institute (NCI) will

publish periodic summaries of proposed

projects to be submitted to the Office of

Management and Budget (OMB) for

review and approval.

PROPOSED COLLECTION: Title: Leukemia

and Other Cancers Among Chernobyl

Clean-up Workers in Lithuania. Type of

Information Collection Request:

renewal. Need and Use of Information

Collections: A cohort study will be

conducted to investigate the risk of

radiation-induced leukemia and other

cancers, and of occupationally related

cancers, among 7,000 workers from

Lithuania who were sent to Chernobyl

to clean-up after the accident there in

1986. The workers will be asked to

respond to a mail questionnaire or an

interview that collects information

about specific duties performed during

the Chernobyl clean-up, occupational

exposures, other cancer risk factors, and

incident cancers. The information will

be combined with similar information

from Estonia and Latvia and used by the

National Cancer Institute to determine

site-specific risk estimates for cancer

based on various exposure patterns.

Frequency of Response: One time;

Affected Public: Individuals or

households; Type of Respondents:

Chernobyl Workers. The annual

reporting burden is as follows:

Estimated Number of Respondents:

7,000; Estimated Number of Responses

per Respondent: 1; Average Burden

Hours per Response: 0.5; and Estimated

Total Annual Burden Hours Requested:

3,500. There are no Capital Costs to

report. There are no Operating or

Maintenance Costs to report.

REQUEST FOR COMMENTS: Written

comments and/or suggestions from the

public and affected agencies are invited

on one or more of the following points:

(a) whether the proposed collection of

information is necessary for the proper

performance of the functions of the

agency, including whether the

information shall have practical utility;

(b) the accuracy of the agency’s estimate

of the burden of the proposed collection

of information; (c) ways to enhance the

quality, utility, and clarity of the

information to be collected; and (d)

ways to minimize the burden of the

collection of information on

respondents, including through the use

of automated collection techniques or

other forms of information technology.

FOR FURTHER INFORMATION CONTACT:

To request more information on the

proposed project or to obtain a copy of

the plans and instruments, contact

Gilbert W. BeeBe, Ph.D., National

Cancer Institute, EPN 400, 6130

Executive Boulevard, Rockville, MD

20892–7364, or call the non-toll-free

number (301) 496–5067.

COMMENTS DUE DATE: Comments

regarding this information collection are

best assured of having their full effect if

received on or before December 8, 1997.

Dated: September 30, 1997.

Nancie L. Bliss,

OMB Project Clearance Liaison.

[FR Doc. 97–26632 Filed 10–7–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Government-Owned Inventions;

Availability for Licensing

AGENCY: National Institutes of Health,

Public Health Service, DHHS.

ACTION: Notice.

SUMMARY: The National Institutes of

Health is seeking licensees for the

further development, evaluation, and

commercialization of novel

progesterone antagonists and

pharmaceutical compositions thereof.

The invention claimed in U.S. Patent

Application 60/016,628 entitled ‘‘21-

Substituted Progesterone Derivatives As

New Antiprogestational Agents’’ (HK

Kim, RP Blye, PN Rao, JW Cessac, and

CK Acosta), filed May 1, 1996, and a

related case filed April 30, 1997, are

available for either exclusive or nonexclusive licensing (in accordance with

35 U.S.C. 207 and 37 CFR Part 404).

ADDRESSES: Licensing proposals and

questions about this opportunity should

be addressed to Ms. Carol Lavrich,